FrancophonIA/ELRC3.0 huggingface dataset:
English: In patients taking REZOLSTA and raltegravir (for HIV infection), rashes (generally mild or moderate) may occur more frequently than in patients taking either medicine separately.
Danish: Patienter, der tager REZOLSTA sammen med raltegravir (mod hiv-infektion), kan hyppigere få udslæt end patienter, der kun får det ene af disse lægemidler.
English: There are no data regarding the use of darunavir or cobicistat in patients with severe hepatic impairment.
Danish: Der foreligger ingen data vedrørende anvendelse af darunavir eller cobicistat til patienter med svært nedsat leverfunktion.
English: Lurasidone Pimozide Sertindole Quetiapine
Danish: Lurasidon Pimozid Sertindol Quetiapin
English: Colloidal silicon dioxide Silicified microcrystalline cellulose Crospovidone
Danish: Silicificeret mikrokrystallinsk cellulose Crospovidon
English: Darunavir binds primarily to plasma α1-acid glycoprotein.
Danish: Darunavir binder især til surt α1-glykoprotein i plasma.
English: Skin and subcutaneous tissue disorders Very common rash (including macular, maculopapular, papular, erythematous, pruritic rash, generalised rash, and allergic dermatitis)
Danish: Hud og subkutane væv meget almindelig udslæt (herunder makuløst, makulopapuløst, papuløst, erytematøst, kløende udslæt, generaliseret udslæt og allergisk dermatitis)
English: Co-administration of REZOLSTA and naloxegol is contraindicated.
Danish: Co-administration af REZOLSTA og naloxegol er kontraindiceret.
English: Common side effects (may affect up to 1 in 10 people) - allergic reactions such as itching - decreased appetite - abnormal dreams - vomiting, pain or swelling of the belly, indigestion, flatulence - muscle pain - tiredness - abnormal blood test results such as some tests for your liver or kidney.
Danish: Almindelige bivirkninger (kan forekomme hos op til 1 ud af 10 personer) - allergiske reaktioner såsom kløe - nedsat appetit - unormale drømme - opkastning, mavesmerter eller -udspiling, fordøjelsesbesvær, luft i tarmene - muskelsmerter - træthed - unormale resultater af blodprøver som for eksempel visse undersøgelser af lever eller nyrer; din læge vil forklare dig om dette - svaghed.
English: The evidence of efficacy of REZOLSTA once daily is based on the analysis of 48 week data from trial GS-US-216-130 in ART-naïve and ART-experienced patients, trial TMC114FD2HTX3001 in ART-naïve patients, and two Phase III trials ARTEMIS and ODIN conducted with darunavir/ritonavir 800/100 mg q.d.
Danish: Dokumentationen for virkningen af REZOLSTA en gang dagligt er baseret på analysen af 48-ugers data fra studiet GS-US-216-130 med ART-naive og ART-erfarne patienter, studiet TMC114FD2HTX3001 med ART-naive patienter og to fase III-studier, ARTEMIS og ODIN, udført med darunavir/ritonavir 800/100 mg dagligt hos henholdsvis ART-naive og ART-erfarne patienter.
English: The combination of colchicine and REZOLSTA is contraindicated in patients with renal or hepatic impairment (see section 4.3).
Danish: Kombination af colchicin og REZOLSTA er kontraindiceret hos patienter med nedsat nyreeller leverfunktion (se pkt.
English: In the 96 week analysis, the safety profile of darunavir/ritonavir 800/100 mg once daily in treatment-naïve subjects was similar to that seen with darunavir/ritonavir 600/100 mg twice daily in treatment-experienced subjects except for nausea which was observed more frequently in treatment-naïve subjects.
Danish: I 96-ugers-analysen svarede sikkerhedsprofilen for darunavir/ritonavir 800/100 mg en gang dagligt hos behandlingsnaive patienter til profilen for darunavir/ritonavir 600/100 mg to gange dagligt hos behandlingserfarne patienter med undtagelse af kvalme, der sås hyppigere hos behandlingsnaive patienter.
English: Imputations according to the TLOVR algorithm Last Observation Carried Forward imputation
Danish: I henhold til TLOVR-algoritmen (time to loss of viral response) I henhold til LOCF (last observation carried forward)
English: Separate trials of darunavir/ritonavir and cobicistat suggest no dose adjustment is recommended in patients with mild (Child-Pugh Class A) or moderate (Child-Pugh Class B) hepatic impairment, however, REZOLSTA should be used with caution in these patients.
Danish: Separate studier med darunavir/ritonavir og cobicistat tyder på, at dosisjustering ikke er nødvendig hos patienter med let (Child-Pugh klasse A) eller moderat (Child-Pugh klasse B) nedsat leverfunktion.
English: Always use this medicine exactly as your doctor, pharmacist or nurse has told you.
Danish: Tag altid lægemidlet nøjagtigt efter lægens, apotekspersonalets eller sundhedspersonalets anvisning.
English: To ensure administration of the entire dose of both darunavir and cobicistat, the tablet should be swallowed whole.
Danish: Tabletten skal synkes hel for at sikre administration af hele dosen af både darunavir og cobicistat.
English: Each tablet contains 800 mg of darunavir (as ethanolate) and 150 mg cobicistat.
Danish: Hver tablet indeholder 800 mg darunavir (som ethanolat) og 150 mg cobicistat.
English: (OATP1B and CYP3A inhibition)
Danish: (OATP1B- og CYP3A-hæmning)
English: Adverse reactions with darunavir/cobicistat in adult patients
Danish: Bivirkninger med darunavir/cobicistat hos voksne patienter
English: Tenofovir alafenamide ↔ Tenofovir ↑
Danish: Emtricitabin/tenofoviralafenamid Tenofoviralafenamid ↔ Tenofovir ↑
English: REZOLSTA should not be used in treatment-experienced patients with one or more DRV-RAMs or HIV-1 RNA ≥ 100,000 copies/mL or CD4+ cell count < 100 cells x 10
Danish: REZOLSTA bør ikke anvendes til behandlingserfarne patienter med en eller flere DRV-RAM hiv-1 RNA ≥ 100.000 kopier/ml eller CD4+-celletal < 100 x 10
English: REZOLSTA and antacids can be used concomitantly without dose adjustment.
Danish: REZOLSTA og antacida kan anvendes samtidig uden dosisjustering.
English: Therefore, REZOLSTA must not be used in patients with severe hepatic impairment (Child-Pugh Class C) (see sections 4.3, 4.4 and 5.2).
Danish: REZOLSTA må derfor ikke anvendes til patienter med svært nedsat leverfunktion (Child-Pugh klasse C) (se pkt.
English: Non-inferiority in virologic response to the darunavir/ritonavir treatment, defined as the percentage of patients with plasma HIV-1 RNA level < 50 copies/mL, was demonstrated (at the pre-defined 12% non-inferiority margin) for both Intent-To-Treat (ITT) and On Protocol (OP) populations in the 48 week analysis.
Danish: Ved 48-ugers-analysen blev non-inferioritet i virologisk respons over for darunavir/ritonavirbehandlingen, defineret som procentdelen af patienter med plasma-hiv-1 RNA < 50 kopier/ml, påvist (ved den forud definerede 12 % non-inferioritetsgrænse) hos begge populationer (”Intent-To-Treat” og ”On Protocol”).
English: HIV Nucleo(s/t)ide reverse transcriptase inhibitors (NRTIs) Didanosine
Danish: Nukleos(t)id-revers-transkriptase-hæmmere (NRTI'er) mod hiv Didanosin
English: Co-administration of REZOLSTA with rifabutin and rifapentine is not recommended.
Danish: Co-administration af REZOLSTA og rifabutin og rifapentin frarådes.
English: Each film-coated tablet contains 800 mg darunavir (as ethanolate) and 150 mg cobicistat.
Danish: Hver filmovertrukken tablet indeholder 800 mg darunavir (som ethanolat) og 150 mg cobicistat.
English: With baseline CD4+ cell count ≥ 200 median CD4+ cell count change from baseline (x 10
Danish: Med CD4+celletal < 200 ved baseline Med CD4+celletal ≥ 200 ved baseline Median ændring i CD4+-celletal fra baseline (x 10
English: Co-administration of tadalafil for the treatment of pulmonary arterial hypertension with REZOLSTA is not recommended.
Danish: Co-administration af REZOLSTA og tadalafil til behandling af pulmonal arteriel hypertension frarådes.
English: Dizziness has been reported in some patients during treatment with regimens containing darunavir administered with cobicistat and should be borne in mind when considering a patient's ability to drive or operate machinery.
Danish: Der er rapporteret om svimmelhed under behandling med regimer, der indeholder darunavir administreret samtidig med cobicistat, hos nogle patienter.
English: Medicinal products that affect darunavir/cobicistat exposure
Danish: Lægemidler, der påvirker eksponeringen for darunavir/cobicistat
English: Treatment with REZOLSTA during pregnancy results in low darunavir exposure (see sections 4.4 and 5.2).
Danish: Behandling med REZOLSTA under graviditet fører til lav eksponering for darunavir (se pkt.
English: Cobicistat is not expected to induce CYP1A2, CYP3A4, CYP2C9, CYP2C19, UGT1A1, or P-gp (MDR1).
Danish: Det forventes ikke, at cobicistat hæmmer CYP1A2, CYP2B6, CYP2C8, CYP2C9 eller CYP2C19, eller at det inducerer CYP1A2, CYP3A4, CYP2C9, CYP2C19, UGT1A1 eller P-gp (MDR1).
English: Non completer is failure imputation: patients who discontinued prematurely are imputed with a change equal to 0
Danish: Patienter, der ikke fuldførte behandlingen, betragtes som havende behandlingssvigt, dvs. patienter, der afbrød behandlingen i utide, medregnes med en ændring, der tillægges størrelsen 0.
English: HIV-1 RNA < 50 copies/mL With Baseline
Danish: Hiv-1 RNA < 50 kopier/ml Med hiv-1 RNA (kopier/ml) ved baseline
English: There were insufficient pharmacokinetic data in the clinical trials to determine the effect of hepatitis B and/or C virus infection on the pharmacokinetics of darunavir and cobicistat (refer to sections 4.4 and
Danish: Samtidig infektion med hepatitis B og/eller hepatitis C Der var utilstrækkelige farmakokinetiske data i de kliniske studier til at bestemme virkningen af hepatitis B- og/eller C-virusinfektion på darunavirs og cobicistats farmakokinetik (se pkt.
English: Co-administration of domperidone with REZOLSTA is contraindicated.
Danish: Co-administration af domperidon og REZOLSTA er kontraindiceret.
English: Concomitant use of PDE-5 inhibitors for the treatment of erectile dysfunction with REZOLSTA should be done with caution.
Danish: Der skal udvises forsigtighed ved samtidig brug af REZOLSTA og PDE-5hæmmere til behandling af erektil dysfunktion.
English: Last Observation Carried Forward imputation
Danish: I henhold til LOCF (last observation carried forward)
English: At 48 weeks, virologic response, defined as the percentage of patients with plasma HIV-1 RNA level < 50 copies/mL, with darunavir/ritonavir 800/100 mg once daily treatment was demonstrated to be non-inferior (at the pre-defined 12% non-inferiority margin) compared to darunavir/ritonavir 600/100 mg twice daily for both ITT and OP populations.
Danish: Det virologiske respons, defineret som procentdelen af patienter med plasma-hiv-1 RNA < 50 kopier/ml, ved behandling med darunavir/ritonavir 800/100 mg en gang dagligt, viste sig efter 48 uger at være non-inferiørt (ved den forud definerede 12 % grænse for non-inferioritet) sammenlignet med darunavir/ritonavir 600/100 mg to gange dagligt hos både ITT- og OP-populationer.
English: Efficacy of darunavir/cobicistat fixed-dose combination 800/150 mg once daily in ART-naïve patients TMC114FD2HTX3001 is a randomized, active-controlled, double blind, Phase III trial to evalate the efficacy and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide versus darunavir/cobicistat fixed-dose combination + emtricitabine/tenofovir disoproxil fumarate.
Danish: TMC114FD2HTX3001 er et randomiseret, aktivt kontrolleret, dobbeltblindt fase III-studie til vurdering af virkningen og sikkerheden af darunavir/cobicistat/emtricitabin/tenofoviralafenamid kontra fastdosis-kombination af darunavir/cobicistat + emtricitabin/tenofovirdisoproxilfumarat.
English: REZOLSTA and raltegravir can be used without dose adjustments.
Danish: REZOLSTA og raltegravir kan anvendes uden dosisjusteringer.
English: The mean eGFRCG change from baseline was -9.6 mL/min at week 2, and -9.6 mL/min at week 48.
Danish: fra baseline ved uge 2 og -9,6 ml/min.
English: REZOLSTA can be used with these NRTIs without dose adjustment.
Danish: REZOLSTA kan anvendes sammen med disse NRTI-midler uden dosisjustering.
English: REZOLSTA should not be used in patients with one or more darunavir resistance associated mutations (DRV-RAMs) or HIV-1 RNA ≥ 100,000 copies/mL or CD4+ cell count < 100 cells x 10
Danish: REZOLSTA bør ikke anvendes til patienter med en eller flere mutationer associeret med darunavirresistens (DRV-RAM), hiv-1 RNA ≥ 100.000 kopier/ml eller CD4+-celletal < 100 x 10 celler/l (se pkt.
English: REZOLSTA 800 mg/150 mg tablets darunavir/cobicistat
Danish: REZOLSTA 800 mg/150 mg tabletter darunavir/cobicistat
English: Among 1,968 treatment-experienced patients receiving darunavir co-administered with ritonavir 600/100 mg twice daily, 236 patients were co-infected with hepatitis B or C. Co-infected patients were more likely to have baseline and treatment emergent hepatic transaminase elevations than those without chronic viral hepatitis (see section 4.4).
Danish: Patienter co-inficeret med hepatitis B og/eller hepatitis C Der foreligger kun begrænsede oplysninger om brug af REZOLSTA hos patienter co-inficeret med hepatitis B og/eller C. Blandt 1.968 behandlingserfarne patienter, der fik darunavir coadministreret med ritonavir, 600/100 mg to gange dagligt, havde 236 patienter også hepatitis B eller C. Disse patienter var mere tilbøjelige til at have forhøjede hepatiske aminotransferaser ved baseline og efter behandlingsstart end patienter uden kronisk viral hepatitis (se pkt.
English: Co-administration of REZOLSTA and efavirenz is not recommended.
Danish: Co-administration af REZOLSTA og efavirenz frarådes.
English: Colchicine (if you have kidney/liver problems) to treat gout or familial Mediterranean fever The combination product lopinavir/ritonavir anti-HIV medicine
Danish: - colchicin (til behandling af urinsur gigt eller familiær middelhavsfeber).
English: If you take more REZOLSTA than you should Contact your doctor, pharmacist or nurse immediately.
Danish: Hvis du har taget for mange REZOLSTA Kontakt straks din læge, apotekspersonalet eller sundhedspersonalet.
English: With Baseline CD4+ cell count (x 10
Danish: Med CD4+-celletal (x 10
English: Clinical monitoring is recommended when co-administering REZOLSTA with beta-blockers and a lower dose of the beta-blocker should be considered.
Danish: Klinisk monitorering anbefales ved co-administration af REZOLSTA og disse betablokkere, og lavere dosis af disse betablokkere bør overvejes.
English: see section 4.5) - sildenafil - when used for the treatment of pulmonary arterial hypertension, avanafil - simvastatin, lovastatin and lomitapide (see section 4.5) - dabigatran, ticagrelor.
Danish: 4.5) - sildenafil til behandling af pulmonal arteriel hypertension, avanafil - simvastatin, lovastatin og lomitapid (se pkt.
English: The interaction profile of darunavir depends on whether ritonavir or cobicistat is used as pharmacokinetic enhancer, therefore there may be different recommendations for the use of darunavir with concomitant medicine.
Danish: Interaktionsprofilen for darunavir afhænger af, om ritonavir eller cobicistat benyttes som farmakokinetisk forstærker.
English: Therapeutic drug monitoring of the immunosuppressive agent must be done when co-administration occurs.
Danish: Ved co-administration er terapeutisk lægemiddelmonitorering af det immunsupprimerende middel nødvendig.
English: The combination of rifampicin and REZOLSTA is contraindicated (see section 4.3).
Danish: Kombinationen af rifampicin og REZOLSTA er kontraindiceret (se pkt.
English: 6/l (see sections 4.2 and 4.4).
Danish: 4.2 og 4.4).
English: (inhibition of CYP3A)
Danish: (hæmning af CYP3A)
English: Common pruritus
Danish: almindelig ikke almindelig pruritus
English: REZOLSTA is expected to increase nevirapine plasma concentrations.
Danish: REZOLSTA forventes at øge plasmakoncentrationen af nevirapin.
English: The safety and efficacy of REZOLSTA in paediatric patients aged 3 to 17 years has not been established (see sections 4.4 and 5.3).
Danish: REZOLSTAs sikkerhed og virkning hos pædiatriske patienter i alderen 3 til 17 år er ikke klarlagt (se pkt.
English: Use of other antiplatelets not affected by CYP inhibition or induction (e.g. prasugrel) is recommended (see section 4.3).
Danish: Det anbefales at bruge andre trombocythæmmende midler, som ikke påvirkes af CYPhæmning eller -induktion (f.eks. prasugrel se pkt.
English: Renal impairment REZOLSTA has not been investigated in patients with renal impairment.
Danish: Nedsat nyrefunktion REZOLSTA er ikke undersøgt hos patienter med nedsat nyrefunktion.
English: lopinavir/ ritonavir 800/200 mg per day N = 346
Danish: lopinavir/ ritonavir 800/200 mg dagligt N=346
English: REZOLSTA and didanosine can be used without dose adjustments.
Danish: REZOLSTA og didanosin kan anvendes uden dosisjustering.
English: Based on theoretical considerations REZOLSTA may increase plasma concentrations of these analgesics.
Danish: Baseret på teoretiske overvejelser kan REZOLSTA muligvis øge plasmakoncentrationen af disse analgetika.
English: Co-administration of REZOLSTA with dapoxetine is contraindicated.
Danish: Co-administration af REZOLSTA og dapoxetin er kontraindiceret.
English: - Corticosteroids including betamethasone, budesonide, fluticasone, mometasone, prednisone,
Danish: Din læge vil muligvis foretage yderligere test. - kortikosteroider, herunder betamethason, budesonid, fluticason, mometason, prednison og triamcinolon.
English: Co-administration of REZOLSTA and these anticonvulsants is contraindicated (see section 4.3).
Danish: Co-administration af REZOLSTA og disse antiepileptika er kontraindicerede (se pkt.
English: Danmark Janssen-Cilag A/S Tlf: +45 4594 8282
Danish: Danmark Janssen-Cilag A/S Tlf: +45 4594 8282 jacdk@its.jnj.com
English: REZOLSTA should not be initiated in patients with creatinine clearance less than 70 mL/min when co-administered with one or more agent requiring dose adjustment based on creatinine clearance (e.g. emtricitabine, lamivudine, tenofovir disoproxil (as fumarate, phosphate or succinate) or adefovir dipivoxil) (see sections 4.2, 4.8 and 5.2).
Danish: Behandling med REZOLSTA bør ikke initieres hos patienter med kreatininclearance under 70 ml/min, hvis dosisjustering på basis af kreatininclearance er nødvendigt for et samtidigt administreret lægemiddel (f.eks. emtricitabin, lamivudin, tenofovirdisoproxil (som fumarat, fosfat eller succinat) eller adefovirdipivoxil) (se pkt.
English: Metabolism and nutrition disorders Common anorexia, hypercholesterolaemia, hypertriglyceridaemia
Danish: Metabolisme og ernæring almindelig anoreksi, hyperkolesterolæmi, hypertriglyceridæmi ikke almindelig diabetes mellitus, dyslipidæmi, hyperglykæmi, hyperlipidæmi
English: Triazolam or oral (taken by mouth) midazolam to help you sleep and/or relieve anxiety Sildenafil to treat a heart and lung disorder called pulmonary arterial hypertension.
Danish: Triazolam eller oral (taget gennem munden) midazolam som sovemiddel og/eller til at afhjælpe angst
English: Based on theoretical considerations REZOLSTA is expected to increase these antifungal plasma concentrations, and darunavir and/or cobicistat plasma concentrations may be increased by the antifungals.
Danish: Baseret på teoretiske overvejelser forventes REZOLSTA at øge plasmakoncentrationen af antimykotika, og plasmakoncentrationen af darunavir og/eller cobicistat kan øges af de pågældende antimykotika.
English: Based on theoretical considerations REZOLSTA is expected to increase concentrations of clonazepam.
Danish: Baseret på teoretiske overvejelser forventes REZOLSTA at øge koncentrationen af clonazepam.
English: Genotypic testing should guide the use of REZOLSTA (see sections 4.2, 4.4 and 5.1).
Danish: Genotypebestemmelse skal være vejledende for brugen af REZOLSTA (se pkt.
English: Based on theoretical considerations REZOLSTA is expected to increase these sedative/hypnotic plasma concentrations.
Danish: Baseret på teoretiske overvejelser forventes REZOLSTA at øge plasmakoncentrationen af disse sedativa/hypnotika.
English: Co-administration of REZOLSTA and nevirapine is not recommended.
Danish: Co-administration af REZOLSTA og nevirapin frarådes.
English: Treatment-naïve darunavir/cobicistat 800/150 mg once daily + emtricitabine/tenofovir disoproxil fumarate N = 363
Danish: Behandlingsnaive darunavir/cobicistat 800/150 mg en gang dagligt + emtricitabine/tenofovirdisoproxilfumarat N = 363
English: Based on theoretical considerations nevirapine is expected to decrease darunavir and/or cobicistat plasma concentrations, (CYP3A induction).
Danish: Baseret på teoretiske overvejelser forventes nevirapin at nedsætte plasmakoncentrationen af darunavir og/eller cobicistat (CYP3A-induktion).
English: (CYP3A, CYP2D6 and/or P-gp inhibition)
Danish: (CYP3A-, CYP2D6- og/eller P-gp-hæmning)
English: In the virologic failures of the GS-US-216-130 trial no cross-resistance with other HIV PIs was observed.
Danish: Der blev ikke observeret krydsresistens med andre hiv-PI'er i de virologiske svigt fra studiet GS-US216-130.
English: REZOLSTA 800 mg/150 mg film-coated tablets darunavir/cobicistat
Danish: REZOLSTA 800 mg/150 mg filmovertrukne tabletter darunavir/cobicistat
English: If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivity, please inform your doctor immediately so you can be given the necessary treatment.
Danish: Du skal straks informere din læge, så du kan få den nødvendige behandling, hvis du bemærker symptomer på infektion eller andre symptomer, såsom muskelsvaghed, svaghed begyndende i hænder og fødder, og som bevæger sig op igennem kroppen, hjertebanken, rysten eller hyperaktivitet.
English: Concomitant use of REZOLSTA with lovastatin and simvastatin is contraindicated (see section 4.3).
Danish: Samtidig brug af REZOLSTA og lovastatin eller simvastatin er kontraindiceret (se pkt.
English: In the REZOLSTA arm of Phase III trial TMC114FD2HTX3001, mean eGFRCG change from baseline was -11.1 mL/min at week 48 and mean eGFRcystatin C change from baseline was +2.9 mL/min/1.73 m² at week 48.
Danish: I REZOLSTA-armen i fase III-studiet TMC114FD2HTX3001 var den gennemsnitlige ændring i eGFRCG fra baseline -11,1 ml/min.
English: REZOLSTA and tenofovir disoproxil can be used without dose adjustments.
Danish: REZOLSTA og tenofovirdisoproxil kan anvendes uden dosisjustering.
English: - Bosentan (to treat high blood pressure in the pulmonary circulation) - Buspirone, clorazepate, diazepam, estazolam, flurazepam, zolpidem, midazolam when used as injection (medicines to treat trouble with sleeping and/or anxiety) - Metformin (to treat type 2 diabetes) - Fentanyl, oxycodone, tramadol (to treat pain).
Danish: - buspiron, clorazepat, diazepam, estazolam, flurazepam, zolpidem og midazolam brugt som injektion (medicin til behandling af søvnforstyrrelser og/eller angst).
English: REZOLSTA should not be used in paediatric patients below 3 years of age (see sections 4.2 and 5.3).
Danish: REZOLSTA bør ikke anvendes til pædiatriske patienter under 3 år (se pkt.
English: Efficacy of darunavir 800 mg once daily co-administered with 100 mg ritonavir once daily in ART-experienced patients
Danish: Virkning af darunavir 800 mg en gang dagligt co-administreret med 100 mg ritonavir en gang dagligt hos ART-erfarne patienter
English: Caution should be exercised when combining one of these anti-neoplastic agents with REZOLSTA.
Danish: Der skal udvises forsigtighed ved kombination af disse antineoplastika og REZOLSTA.
English: Common vomiting, abdominal pain, abdominal distension, dyspepsia, flatulence
Danish: Mave-tarm-kanalen meget almindelig diarré, kvalme almindelig opkastning, abdominalsmerter, abdominal distention, dyspepsi, flatulens ikke almindelig akut pankreatitis, forhøjede pankreasenzymer